Renal proximal tubular cell growth and differentiation are differentially modulated by renotropic growth factors and tyrosine kinase inhibitors

European Journal of Clinical Investigation

Volumn 31, Issue 12, 2001, Pages 1029-1039

  Ernst, F ^a   Hetzel, S ^a   Stracke, S ^a   Czock, D ^a   Vargas, G ^a   Lutz, M P ^a   Keller, F ^a   Jehle, Peter M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cell growth and differentiation; Growth factors; Receptors; Renal proximal tubular cells; Tyrosine kinase inhibitors

Indexed keywords

CINNAMIC ACID DERIVATIVE; EMODIN; EPIDERMAL GROWTH FACTOR; GELDANAMYCIN; GENISTEIN; GROWTH FACTOR; LAVENDUSTIN A; METHYL 2,5 DIHYDROXYCINNAMATE; PROTEIN TYROSINE KINASE INHIBITOR; SCATTER FACTOR; SOMATOMEDIN; TYRPHOSTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME INHIBITION; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; LIGAND BINDING; MICROVILLUS; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BINDING, COMPETITIVE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR I; IODINE RADIOISOTOPES; KIDNEY TUBULES, PROXIMAL; PROTEIN-TYROSINE KINASES; RABBITS; RECEPTORS, GROWTH FACTOR;

EID: 0035791033     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00925.x     Document Type: Article

References (42)

1. Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem 1993;62:453-81.
2. Ullrich A, Schlesinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12.
3. Heldin CH. Dimerization of cell surface receptors in signal transduction. Cell 1995;80:213-23.
4. Hammerman MR, Miller SB. The growth hormone insulin-like growth factor axis in kidney revisited. Am J Physiol 1993;265:F1-F14.
5. Haug C, Grill C, Schmid-Kotsas A, Gruenert A, Jehle PM. Endothelin release by rabbit proximal tubule cells: modulatory effects of cyclosporine A, tacrolimus, HGF and EGF. Kidney Int 1998;54:1626-36.
6. Jehle PM, Fussgaenger RD, Stracke S, Grunewald RW, Keller F. Different binding and degradation of proinsulin, insulin and IGF-1 in cultured renal proximal tubular cells: Implications for the prolonged serum half-life of proinsulin. Acta Diabetol 1996;33:159-65.
7. Terzi F, Burtin M, Hekmati M, Federici P, Grimber G, Briand P et al. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest 2000;106:225-34.
8. Wang S, Hirschberg R. Role of growth factors in acute renal failure. Nephrol Dial Transplant 1997;12:1560-3.
9. Vargas GA, Hoeflich A, Jehle PM. Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 2000;57:1426-36.
10. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993;265:F61-F69.
11. Hammerman MR. Potential role of gowth factors in the prophylaxis and treatment of acute renal failure. Kidney Int (Suppl) 1998;64:S19-S22.
12. Harris RC. Growth factors and cytokines in acute renal failure. Adv Ren Replace Ther 1997;4:43-53.
13. Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 1989;84:1757-61.
14. Humes HD. Acute renal failure-the promise of new therapies. N Engl J Med 1997;336:870-1.
15. Norman J, Tsau YK, Bacay A, Fine LG. Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: Role of the epidermal growth factor receptor. Clin Sci Colch 1990;78:445-50.
16. Miller SB, Martin DR, Kissane J, Hammerman MR. Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 1992;89:11876-80.
17. Schena FP. Role of growth factors in acute renal failure. Kidney Int 1998;66(Suppl):S11-S15.
18. Vijayan A, Franklin SC, Behrend T, Hammerman MR, Miller SB. Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure. Am J Physiol 1999;276:R929-R934.
19. Franklin SC, Moulton M, Sicard GA, Hammerman MR, Miller SB. Insulin-like growth factor I preserves renal function postoperatively. Am J Physiol 1997;272:F257-F259.
20. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999;55:2423-32.
21. Wang SN, LaPage J, Hirschberg R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 2000;57:1002-14.
22. Stracke S, Ernst F, Jehle DR, Grunewald RW, Haller H, Keller F et al. Differentiating and proliferative effects of HGF in renal proximal tubular cells are mediated via different signalling pathways. Nephrol Dial Transplant 1998;13:1398-405.
23. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
24. El-Zarruk AA, van den Berg HW. The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase. Cancer Lett 1999;142:185-93.
25. Janicot M, Flores-Riveros JR, Lane MD. The insulin-like growth factor 1 (IGF-1) receptor is responsible for mediating the effects of insulin, IGF-1, and IGF-2 in Xenopus laevis oocytes. J Biol Chem 1991;266:9382-91.
26. Jayasuriya H, Koonchanok NM, Geahlen RL, McLaughlin JL, Chang CJ. Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. J Nat Prod 1992;55:696-8.
27. Kiehne K, Herzig KH, Folsch UR. C-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth. Pancreas 1997;15:35-40.
28. MacKenzie WM, Hoskin DW, Blay J. The adhesion of anti-CD3-activated mouse T cells to protein syngeneic colon adenocarcinoma cells is differentially regulated by tyrosine kinase-, protein kinase C-, and cAMP-dependent pathways in the effector cell. Biochem Biophys Res Commun 1999;255:460-5.
29. Parrizas M, Gazit A, Levitzki A, Wertheimer E, LeRoith D. Specific inhibition of insulin-like growth factor-I and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 1997;138:1427-33.
30. Uehara Y, Fukazawa H, Murakami Y, Mizuno S. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem Biophys Res Commun 1989;163:803-9.
31. Jehle PM, Fussgaenger RD, Angelus NK, Jungwirth RJ, Saile B, Lutz MP. Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors. Am J Physiol 1999;276:E262-E268.
32. Meibohm B, Derendorf H. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. Int J Clin Pharmacol Ther 1997;35:401-13.
33. Weiner DL. NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models. Meth Find Exp Clin Pharmacol 1986;8:625-8.
34. Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM et al. Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer 1996;69:212-7.
35. Bardelli A, Pugliese L, Comoglio PM. 'Invasive growth' signaling by the Met/HGF receptor: the hereditary renal carcinoma connection. Biochim Biophys Acta 1997;1333:M41- M51.
36. Druker BJ, Lydon NB. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest 2000;105:3-7.
37. Ding H, Kopple JD, Cohen A, Hischberg R. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 1993;91:2281-7.
38. Kawaida K, Matsumoto K, Shimazu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994;91:4357-61.
39. LeRoith D. Insulin-like growth factors. N Engl J Med 1997;336:633-40.
40. Brinkmann V, Foroutan H, Sachs M, Weidner KM, Birchmeier W. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol 1995;131:1573-86.
41. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci 1997;94:701-6.
42. Bradbury J. A two-pronged approach to the clinical use of HGF. Lancet 1998;351:272.